A Complement Renaissance

FEATUREComplement A Complement Renaissance BY M. KATHRYN LISZEWSKI AND JOHN P. ATKINSONARTICLE EXTRASRelated Article:A Complementary PathwayHow one group of researchers brought a scientific idea to the clinic for a rare diseaseInfographics: Interrupting ComplementPaths to MarketWeb Extra:Margarita Soto: A life with PNHMore than 600 million years ago, primitive components of the complement system lik

Written byM. Kathryn Liszewski and John P. Atkinson
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share


BY M. KATHRYN LISZEWSKI AND JOHN P. ATKINSON

More than 600 million years ago, primitive components of the complement system likely fashioned the first humoral immune system. The modern complement system comprises more than 30 proteins that react in a dizzying array of interconnectedness to identify and quell invading pathogens. Within seconds of activation, millions of fragments may be released into the milieu to trigger a local inflammatory reaction.

Because of its proinflammatory, immune-enhancing, and destructive capabilities, tight regulation is critical. It should come as no surprise, then, that nearly half of complement's components act to mitigate its effects. Host tissues normally express such inhibitors and are protected. And recent work from our lab and others has shown how pathogens such as smallpox and monkeypox have co-opted this regulation. The monkeypox inhibitor of complement enzymes (MOPICE) serves as a virulence factor because it is closely related to human proteins (such ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies